Published online May 26, 2022. doi: 10.12998/wjcc.v10.i15.5042
Peer-review started: December 2, 2021
First decision: January 8, 2022
Revised: January 22, 2022
Accepted: March 27, 2022
Article in press: March 27, 2022
Published online: May 26, 2022
Processing time: 173 Days and 7.3 Hours
Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by systemic inflammatory response syndrome and vasculopathy. SARS-CoV-2 associated mortality ranges from 2% to 6%. Liver dysfunction was observed in 14%-53% of COVID-19 cases, especially in moderate severe cases. However, no cases of spontaneous hepatic rupture in pregnant women with SARS-CoV-2 have been reported.
A 32-year-old pregnant patient (gestational age: 32 wk + 4 d) without any remarkable medical history or long-term medication presented with epigastralgia. Infectious, non-infectious, and pregnancy-related hepatopathies were excluded. Sudden onset of right subcostal pain with D-dimer and liver enzyme elevation was followed by shock with thrombocytopenia. While performing an emergency cesarean section, hemoperitoneum was observed, and the patient delivered a stillbirth. A 6-cm liver rupture at the edges of segments V and VI had occurred, which was sutured and drained. SARS-CoV-2 positivity on reverse transcription-polymerase chain reaction was confirmed. Further revisions for intrahepatic hematoma with hemorrhagic shock and abdominal compartment syndrome were performed. Subsequently, the patient developed hemoptysis, which was treated using bronchoscopic therapy and non-invasive ventilation. Liver tissue biopsy revealed hemorrhagic foci and necrosis with an irregular centrilobular distribution. Antiphospholipid syndrome and autoimmune hepatitis were also ruled out. Fetal death was caused by acute intrauterine asphyxia.
This case reveals that pregnant women with SARS-CoV-2 infection may be predisposed to liver parenchyma disease with liver rupture.
Core Tip: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may contribute to the worsening of hepatopathy during pregnancy, because of its effect on the endothelium in the systemic inflammatory response syndrome microenvironment. Liver rupture causes high mortality in both the mother and fetus. Such a life-threatening scenario requires close collaboration between the obstetrician and the surgeon with an urgent indication for cesarean section, preferably by midline laparotomy with meticulous control of the liver and treatment of any injury. The presence of SARS-CoV-2 in pregnant women and its association with the development of severe hepatopathy in pregnancy requires further research.